151 related articles for article (PubMed ID: 37489216)
1. Skeletal-Related Events in Renal Cell Carcinoma: Prediction With Alkaline Phosphatase (ALP), C-reactive Protein (CRP), Haemoglobin (Hb) and Erythrocyte Sedimentation Rate (ESR) (A.C.H.E.) Score for Risk Stratification.
Singh Y; Barua SK; Trivedi S; Tp R; Pratim Kashyap M; Kumar Agrawal L; Kumar Pathak U; Garg N
Cureus; 2023 Jun; 15(6):e40835. PubMed ID: 37489216
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for bone metastasis from renal cell cancer.
Chen XY; Lan M; Zhou Y; Chen WZ; Hu D; Liu JM; Huang SH; Liu ZL; Zhang ZH
J Bone Oncol; 2017 Nov; 9():29-33. PubMed ID: 29159028
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of risk factors for bone metastasis in newly diagnosed prostate cancer patients.
Peng C; Juan C; Mao W; Jinghe Y; Renli T
Eur Rev Med Pharmacol Sci; 2022 Jun; 26(11):3832-3839. PubMed ID: 35731052
[TBL] [Abstract][Full Text] [Related]
4. Neuron-Specific Enolase and Hemoglobin as Risk Factors of Intraocular Metastasis in Patients with Renal Cell Carcinoma.
Li QY; Su T; Shi WQ; Fang JW; Zhang MY; Xu QH; Liang RB; Ge QM; Li B; Shao Y
Dis Markers; 2022; 2022():2883029. PubMed ID: 35502301
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the doubling time of serum C-reactive protein and alkaline phosphatase levels in primary bone and soft tissue tumors.
Yudoh K; Matsui H; Kamanori M; Ohmori K; Yasuda T; Tsuji H; Tatezaki S
Jpn J Cancer Res; 1996 Dec; 87(12):1288-95. PubMed ID: 9045965
[TBL] [Abstract][Full Text] [Related]
6. Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.
Huang P; Lan M; Peng AF; Yu QF; Chen WZ; Liu ZL; Liu JM; Huang SH
PLoS One; 2017; 12(9):e0183835. PubMed ID: 28902911
[TBL] [Abstract][Full Text] [Related]
7. Different Expression of Erythrocyte Sedimentation Rate and C-reactive Protein in Papillary Thyroid Carcinoma and Nodular Goiter.
Hou X; Jiang L; Chen C; Zhu X; Ge M
Clin Lab; 2015; 61(7):793-9. PubMed ID: 26299079
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for skeletal-related events (SREs) and factors affecting SRE-free survival for nonsmall cell lung cancer patients with bone metastases.
Ulas A; Bilici A; Durnali A; Tokluoglu S; Akinci S; Silay K; Oksuzoglu B; Alkis N
Tumour Biol; 2016 Jan; 37(1):1131-40. PubMed ID: 26276360
[TBL] [Abstract][Full Text] [Related]
10. The use of receiver operating characteristics analysis in determining erythrocyte sedimentation rate and C-reactive protein levels in diagnosing periprosthetic infection prior to revision total hip arthroplasty.
Ghanem E; Antoci V; Pulido L; Joshi A; Hozack W; Parvizi J
Int J Infect Dis; 2009 Nov; 13(6):e444-9. PubMed ID: 19473865
[TBL] [Abstract][Full Text] [Related]
11. Risk factors associated with skeletal-related events following discontinuation of denosumab treatment among patients with bone metastases from solid tumors: A real-world machine learning approach.
Jacobson D; Cadieux B; Higano CS; Henry DH; Bachmann BA; Rehn M; Stopeck AT; Saad H
J Bone Oncol; 2022 Jun; 34():100423. PubMed ID: 35378840
[TBL] [Abstract][Full Text] [Related]
12. Erythrocyte sedimentation rate and anaemia are independent predictors of survival in patients with clear cell renal cell carcinoma.
Choi Y; Park B; Kim K; Jeong BC; Seo SI; Jeon SS; Choi HY; Lee JE; Lee HM
Br J Cancer; 2013 Feb; 108(2):387-94. PubMed ID: 23299540
[TBL] [Abstract][Full Text] [Related]
13. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma.
Park G; Song SY; Ahn JH; Kim WL; Lee JS; Jeong SY; Park JW; Choi EK; Choi W; Jung IH
Radiat Oncol; 2019 Jul; 14(1):116. PubMed ID: 31272506
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of common preoperative laboratory variables in clear cell renal cell carcinoma.
Lee SE; Byun SS; Han JH; Han BK; Hong SK
BJU Int; 2006 Dec; 98(6):1228-32. PubMed ID: 17034508
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of erythrocyte sedimentation rate and C-reactive protein in Behcet's disease activity and manifestations: a cross-sectional study.
Parsaei A; Moradi S; Masoumi M; Davatchi F; Najafi A; Kooshki AM; Hajighadery A; Akhlaghi M; Faezi T; Kavosi H
BMC Rheumatol; 2022 Feb; 6(1):9. PubMed ID: 35144674
[TBL] [Abstract][Full Text] [Related]
16. The predictive value of C-reactive protein and erythrocyte sedimentation rate for 18F-FDG PET/CT outcome in patients with fever and inflammation of unknown origin.
Balink H; Veeger NJ; Bennink RJ; Slart RH; Holleman F; van Eck-Smit BL; Verberne HJ
Nucl Med Commun; 2015 Jun; 36(6):604-9. PubMed ID: 25738560
[TBL] [Abstract][Full Text] [Related]
17. Evidence of impaired cartilage/bone turnover in patients with active ankylosing spondylitis.
Marhoffer W; Stracke H; Masoud I; Scheja M; Graef V; Bolten W; Federlin K
Ann Rheum Dis; 1995 Jul; 54(7):556-9. PubMed ID: 7668898
[TBL] [Abstract][Full Text] [Related]
18. What are the Optimal Cutoff Values for ESR and CRP to Diagnose Osteomyelitis in Patients with Diabetes-related Foot Infections?
Lavery LA; Ahn J; Ryan EC; Bhavan K; Oz OK; La Fontaine J; Wukich DK
Clin Orthop Relat Res; 2019 Jul; 477(7):1594-1602. PubMed ID: 31268423
[TBL] [Abstract][Full Text] [Related]
19. Risk factors of skeletal-related events in patients with bone metastasis from non-small cell lung cancer undergoing treatment with zoledronate-a post hoc analysis of a randomized clinical trial.
Miyashita H; Cruz C; Smith C
Support Care Cancer; 2021 Mar; 29(3):1629-1633. PubMed ID: 32747990
[TBL] [Abstract][Full Text] [Related]
20. Prediction of postoperative survival by preoperative serum concentrations of anti-p53 compared to CEA, CA 50, CA 242 and conventional blood tests in patients with colorectal carcinoma.
Forslund A; Engarås B; Lönnroth C; Lundholm K
Int J Oncol; 2002 May; 20(5):1013-8. PubMed ID: 11956598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
